Gene · 6375
Papers2,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,385
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NK cells in SARS-CoV-2 infection. | Cent Eur J Immunol | 2022 | 35600151 | PubTator, text mining | PubMed |
| Antigen targeting to dendritic cells: Still a place in future immunotherapy? | Eur J Immunol | 2022 | 35598160 | PubTator, text mining | PubMed |
| Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats. | Neurotoxicology | 2022 | 35594946 | PubTator, text mining | PubMed |
| Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency. | J Clin Immunol | 2022 | 35589883 | PubTator, text mining | PubMed |
| Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells. | J Immunother Cancer | 2022 | 35580928 | PubTator, text mining | PubMed |
| Generation and clinical potential of functional T lymphocytes from gene-edited pluripotent stem cells. | Exp Hematol Oncol | 2022 | 35568954 | PubTator, text mining | PubMed |
| Hypoxia as a Modulator of Inflammation and Immune Response in Cancer. | Cancers (Basel) | 2022 | 35565420 | PubTator, text mining | PubMed |
| The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective? | Int J Mol Sci | 2022 | 35562894 | PubTator, text mining | PubMed |
| Design and discovery of metamorphic proteins. | Curr Opin Struct Biol | 2022 | 35561475 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer. | Cell Prolif | 2022 | 35560676 | PubTator, text mining | PubMed |
| Landscape of Peripheral Blood Mononuclear Cells and Soluble Factors in Severe COVID-19 Patients With Pulmonary Fibrosis Development. | Front Immunol | 2022 | 35558069 | PubTator, text mining | PubMed |
| Characterization of Immunogenicity of Malignant Cells with Stemness in Intrahepatic Cholangiocarcinoma by Single-Cell RNA Sequencing. | Stem Cells Int | 2022 | 35530414 | PubTator, text mining | PubMed |
| Exploring Tumor Immune Microenvironment and Its Associations With Molecular Characteristics in Melanoma. | Front Oncol | 2022 | 35530341 | PubTator, text mining | PubMed |
| T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation. | J Clin Immunol | 2022 | 35527320 | PubTator, text mining | PubMed |
| CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk. | Nat Genet | 2022 | 35513723 | PubTator, text mining | PubMed |
| Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma. | J Inflamm Res | 2022 | 35509325 | PubTator, text mining | PubMed |
| Massively parallel sequencing uncovered disease-associated variant spectra of glucose-6-phosphate dehydrogenase deficiency, phenylketonuria and galactosemia in Vietnamese pregnant women. | Mol Genet Genomic Med | 2022 | 35502621 | PubTator, text mining | PubMed |
| Essential m6A Methylation Regulator HNRNPC Serves as a Targetable Biomarker for Papillary Renal Cell Carcinoma. | J Oncol | 2022 | 35502201 | PubTator, text mining | PubMed |
| In silico screening for oligopeptides useful as capture and reporting probes for interleukin-6 biosensing. | RSC Adv | 2022 | 35497015 | PubTator, text mining | PubMed |
| GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway. | Cell Death Dis | 2022 | 35490166 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6375/papers?page=41